• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颜色感知可区分阿尔茨海默病 (AD) 患者和血管性痴呆 (VaD) 患者。

Color perception differentiates Alzheimer's Disease (AD) from Vascular Dementia (VaD) patients.

机构信息

Department of Psychiatry,University Of Oxford,Oxford,UK.

First Department of Neurology,AHEPA Hospital,Aristotle University of Thessaloniki,Thessaloniki,Greece.

出版信息

Int Psychogeriatr. 2017 Aug;29(8):1355-1361. doi: 10.1017/S1041610217000096. Epub 2017 Mar 22.

DOI:10.1017/S1041610217000096
PMID:28325166
Abstract

BACKGROUND

Alzheimer's Disease (AD) and Vascular Dementia (VaD) are the most common causes of dementia in older people. Both diseases appear to have similar clinical symptoms, such as deficits in attention and executive function, but specific cognitive domains are affected. Current cohort studies have shown a close relationship between αβ deposits and age-related macular degeneration (Johnson et al., 2002; Ratnayaka et al., 2015). Additionally, a close link between the thinning of the retinal nerve fiber (RNFL) and AD patients has been described, while it has been proposed that AD patients suffer from a non-specific type of color blindness (Pache et al., 2003).

METHODS

Our study included 103 individuals divided into three groups: A healthy control group (n = 35), AD (n = 32) according to DSM-IV-TR, NINCDS-ADRDA criteria, and VaD (n = 36) based on ΝΙΝDS-AIREN, as well as Magnetic Resonance Imaging (MRI) results. The severity of patient's cognitive impairment, was measured with the Mini-Mental State Examination (MMSE) and was classified according to the Reisberg global deterioration scale (GDS). Visual perception was examined using the Ishihara plates: "Ishihara Color Vision Test - 38 Plate."

RESULTS

The three groups were not statistically different for demographic data (age, gender, and education). The Ishihara color blindness test has a sensitivity of 80.6% and a specificity of 87.5% to discriminate AD and VaD patients when an optimal (32.5) cut-off value of performance is used.

CONCLUSIONS

Ishihara Color Vision Test - 38 Plate is a promising potential method as an easy and not time-consuming screening test for the differential diagnosis of dementia between AD and VaD.

摘要

背景

阿尔茨海默病(AD)和血管性痴呆(VaD)是老年人中最常见的痴呆症病因。这两种疾病的临床症状似乎相似,例如注意力和执行功能缺陷,但受影响的特定认知领域不同。目前的队列研究表明,αβ 沉积与年龄相关性黄斑变性(AMD)之间存在密切关系(Johnson 等人,2002 年;Ratnayaka 等人,2015 年)。此外,AD 患者的视网膜神经纤维(RNFL)变薄之间存在密切联系,而据报道,AD 患者患有非特异性类型的色盲(Pache 等人,2003 年)。

方法

我们的研究包括 103 名个体,分为三组:健康对照组(n = 35)、根据 DSM-IV-TR、NINCDS-ADRDA 标准诊断的 AD 组(n = 32)和基于 ΝΙΝDS-AIREN 的 VaD 组(n = 36),以及磁共振成像(MRI)结果。使用简易精神状态检查(MMSE)测量患者认知障碍的严重程度,并根据 Reisberg 总体恶化量表(GDS)进行分类。使用 Ishihara 板检查视力:“Ishihara 色盲测试 - 38 板”。

结果

三组在人口统计学数据(年龄、性别和教育程度)方面没有统计学差异。当使用最佳(32.5)性能截断值时,Ishihara 色盲测试对区分 AD 和 VaD 患者具有 80.6%的敏感性和 87.5%的特异性。

结论

Ishihara 色盲测试 - 38 板是一种很有前途的潜在方法,作为一种简单且不耗时的筛选测试,用于 AD 和 VaD 之间的痴呆症鉴别诊断。

相似文献

1
Color perception differentiates Alzheimer's Disease (AD) from Vascular Dementia (VaD) patients.颜色感知可区分阿尔茨海默病 (AD) 患者和血管性痴呆 (VaD) 患者。
Int Psychogeriatr. 2017 Aug;29(8):1355-1361. doi: 10.1017/S1041610217000096. Epub 2017 Mar 22.
2
Color vision test to differentiate Alzheimer's disease from vascular dementia.色觉测试区分阿尔茨海默病与血管性痴呆。
Int Psychogeriatr. 2017 Oct;29(10):1753. doi: 10.1017/S1041610217001089. Epub 2017 Jun 19.
3
The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach.6套临床标准用于在尸检确诊病例中对阿尔茨海默病和血管性痴呆进行分类的有效性和可靠性:决策树方法的附加价值
Dement Geriatr Cogn Disord. 2003;16(3):170-80. doi: 10.1159/000071006.
4
Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.心血管健康研究认知研究中血管性痴呆的分类
Neurology. 2005 May 10;64(9):1539-47. doi: 10.1212/01.WNL.0000159860.19413.C4.
5
Vasoreactivity induced by acetazolamide in patients with vascular dementia versus Alzheimer's disease.乙酰唑胺对血管性痴呆与阿尔茨海默病患者血管反应性的影响
J Neurol Sci. 2009 Aug 15;283(1-2):32-5. doi: 10.1016/j.jns.2009.02.363. Epub 2009 Apr 16.
6
Vascular dementia and Alzheimer's disease: the unsolved problem of clinical and neuropsychological differential diagnosis.血管性痴呆与阿尔茨海默病:临床及神经心理学鉴别诊断的未解难题。
Int J Neurosci. 2005 Dec;115(12):1657-67. doi: 10.1080/00207450590958501.
7
[Comparative study on the clinical features of Alzheimer's disease and vascular dementia].[阿尔茨海默病与血管性痴呆临床特征的比较研究]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Apr;26(2):122-7.
8
Determinants of vascular dementia in the Cardiovascular Health Cognition Study.心血管健康认知研究中血管性痴呆的决定因素
Neurology. 2005 May 10;64(9):1548-52. doi: 10.1212/01.WNL.0000160115.55756.DE.
9
Limitations in differentiating vascular dementia from Alzheimer's disease with brief cognitive tests.通过简短认知测试区分血管性痴呆和阿尔茨海默病的局限性。
Arq Neuropsiquiatr. 2010 Apr;68(2):185-8. doi: 10.1590/s0004-282x2010000200006.
10
Impaired attention function based on the Montréal Cognitive Assessment in vascular dementia patients with frontal hypoperfusion: The Osaki-Tajiri project.基于蒙特利尔认知评估量表的额叶灌注不足血管性痴呆患者注意力功能受损:尾崎-田尻项目
J Clin Neurosci. 2016 Jun;28:128-32. doi: 10.1016/j.jocn.2015.08.047. Epub 2016 Jan 6.

引用本文的文献

1
Color memory as a diagnostic test for mild cognitive impairment and early stage of Alzheimer's disease.颜色记忆作为轻度认知障碍和阿尔茨海默病早期的诊断测试。
Front Neurol. 2025 May 27;16:1589335. doi: 10.3389/fneur.2025.1589335. eCollection 2025.
2
MINDSETS: Multi-omics Integration with Neuroimaging for Dementia Subtyping and Effective Temporal Study.思维模式:多组学与神经影像学相结合用于痴呆症亚型分类及有效的时间研究
Sci Rep. 2025 May 6;15(1):15835. doi: 10.1038/s41598-025-97674-0.
3
Neuropsychological differential diagnosis of Alzheimer's disease and vascular dementia: a systematic review with meta-regressions.
阿尔茨海默病与血管性痴呆的神经心理学鉴别诊断:一项包含元回归分析的系统评价
Front Aging Neurosci. 2023 Nov 6;15:1267434. doi: 10.3389/fnagi.2023.1267434. eCollection 2023.
4
Vision impairment and cognitive decline among older adults: a systematic review.老年人的视力障碍与认知衰退:一项系统综述
BMJ Open. 2022 Jan 6;12(1):e047929. doi: 10.1136/bmjopen-2020-047929.
5
Deficits in color detection in patients with Alzheimer disease.阿尔茨海默病患者的颜色检测缺陷。
PLoS One. 2022 Jan 4;17(1):e0262226. doi: 10.1371/journal.pone.0262226. eCollection 2022.
6
Diagnosis of Alzheimer's Disease in Developed and Developing Countries: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy.发达国家和发展中国家阿尔茨海默病的诊断:诊断试验准确性的系统评价和荟萃分析
J Alzheimers Dis Rep. 2021 Jan 11;5(1):15-30. doi: 10.3233/ADR-200263.
7
Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview.阿尔茨海默病的视觉特征:从基础机制到临床概述。
Neural Plast. 2018 Oct 14;2018:2941783. doi: 10.1155/2018/2941783. eCollection 2018.